21 CFR Part 312 · Investigational New Drug Application

21 CFR 312.52

Transfer of obligations to a contract research organization

21 CFR 312.52 is the regulation titled “Transfer of obligations to a contract research organization” in 21 CFR Part 312, Investigational New Drug Application. Since 2021, 1 FDA warning letter has cited it.

Letters citing it
1 since 2021
Jan 1 to Oct 30, 2026
0 against 0 on the same dates in 2025
Most often cited with
21 CFR 312.2, in 1 letter
Closed out
0% of these letters have a published close-out
See the letter citing 21 CFR 312.52 →

Letters citing it, by year issued

It is a drug letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.

  1. 02021
  2. 02022
  3. 02023
  4. 02024
  5. 12025
  6. 02026

The regulation

Read the text of 21 CFR 312.52 (eCFR, as of Sep 1, 2026)

(a) A sponsor may transfer responsibility for any or all of the obligations set forth in this part to a contract research organization. Any such transfer shall be described in writing. If not all obligations are transferred, the writing is required to describe each of the obligations being assumed by the contract research organization. If all obligations are transferred, a general statement that all obligations have been transferred is acceptable. Any obligation not covered by the written description shall be deemed not to have been transferred.

(b) A contract research organization that assumes any obligation of a sponsor shall comply with the specific regulations in this chapter applicable to this obligation and shall be subject to the same regulatory action as a sponsor for failure to comply with any obligation assumed under these regulations. Thus, all references to “sponsor” in this part apply to a contract research organization to the extent that it assumes one or more obligations of the sponsor.

Text from eCFR as of Sep 1, 2026.

Cited alongside it

Regulations that appear in the same letters as 21 CFR 312.52.

Latest letters citing it

The letter citing 21 CFR 312.52 that FDA posted most recently.

See the letter citing 21 CFR 312.52 →
For regulated teams

Put this kind of reading to
work on your own records.

Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.

Counts include every citation in a letter, as the Letters filter does. How this database is built.

Every letter by dateHow this database is built

FDA Warning Letter Alerts

Share this view

Send the same filters, search and view to a colleague.

You choose what to post or send. Sharing a link does not change access to this site.